Connect your AI

Organon OGN Other Income (Expense)

Other Income (Expense) at other companies

AmgenAMGN

$75M-95.1%

The Cooper Companies, Inc.COO

$3.5M+122%

BiogenBIIB

-$1.1M-144%

Amneal Pharmaceuticals, Inc.AMRX

-$61.6M+2.0%

Envista Holdings CorporationNVST

-$2.9M-314%

ViatrisVTRS

-$47.5M+52.2%

Other financials

Income statement

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

Market cap$3.53B-59.4%

Profitability

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Organon's other income (expense)?: Organon (OGN) reported other income (expense) of -$7M in Q1 2026.
How has Organon's other income (expense) changed year-over-year?: Organon's other income (expense) decreased by 275.0% year-over-year, from $4M to -$7M.
What is the long-term trend for Organon's other income (expense)?: Over 3 years (2022 to 2025), Organon's other income (expense) has grown at a 8.4% compound annual growth rate (CAGR), from -$11M to -$14M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.